tiprankstipranks
Advertisement
Advertisement

AU:PYC Stock Latest News

PYC Therapeutics Issues New Shares Following Option Exercise and Lodges Cleansing Notice
Company AnnouncementsPYC Therapeutics Issues New Shares Following Option Exercise and Lodges Cleansing Notice
2d ago
PYC
PYC Therapeutics Lists Additional 250,000 Shares on ASX
PremiumCompany Announcements
PYC Therapeutics Lists Additional 250,000 Shares on ASX
2d ago
PYC
PYC Therapeutics Advances Genetic Disease Pipeline After $600m Capital Raise
PremiumCompany Announcements
PYC Therapeutics Advances Genetic Disease Pipeline After $600m Capital Raise
3d ago
PYC
PYC Wins EMA Orphan Status for RP11 Gene Therapy Candidate VP-001
PremiumCompany Announcements
PYC Wins EMA Orphan Status for RP11 Gene Therapy Candidate VP-001
4d ago
PYC
PYC Therapeutics Wins Safety Nod to Advance ADOA Drug PYC-001 to Multi-Dose Trial
PremiumCompany Announcements
PYC Therapeutics Wins Safety Nod to Advance ADOA Drug PYC-001 to Multi-Dose Trial
16d ago
PYC
PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
PremiumCompany AnnouncementsPYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
1M ago
PYC
PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress
Premium
Company Announcements
PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress
1M ago
PYC
PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial
Premium
Company Announcements
PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial
1M ago
PYC
PYC Therapeutics: Strengthened Balance Sheet and Expanded Development Plan Underpin Continued Buy Rating
PremiumRatings
PYC Therapeutics: Strengthened Balance Sheet and Expanded Development Plan Underpin Continued Buy Rating
1M ago
PYC Therapeutics CEO Increases Shareholding and Awaits Approval for New Options Grant
PremiumCompany Announcements
PYC Therapeutics CEO Increases Shareholding and Awaits Approval for New Options Grant
2M ago
PYC
PYC Therapeutics Seeks ASX Quotation for Over 10.5 Million New Shares
PremiumCompany Announcements
PYC Therapeutics Seeks ASX Quotation for Over 10.5 Million New Shares
2M ago
PYC
PYC Therapeutics Seeks ASX Quotation for Over 31 Million New Shares
PremiumCompany Announcements
PYC Therapeutics Seeks ASX Quotation for Over 31 Million New Shares
2M ago
PYC
PYC Therapeutics appoints new joint company secretary to oversee ASX compliance
PremiumCompany AnnouncementsPYC Therapeutics appoints new joint company secretary to oversee ASX compliance
2M ago
PYC
PYC Therapeutics Completes $47m Retail Entitlement Offer, Boosting Capital for RNA Programs
Premium
Company Announcements
PYC Therapeutics Completes $47m Retail Entitlement Offer, Boosting Capital for RNA Programs
2M ago
PYC
PYC Therapeutics Issues Cautious Q1 2026 Investor Update
Premium
Company Announcements
PYC Therapeutics Issues Cautious Q1 2026 Investor Update
2M ago
PYC
PYC Therapeutics Files Interim Results as RNA Pipeline Advances
PremiumCompany Announcements
PYC Therapeutics Files Interim Results as RNA Pipeline Advances
2M ago
PYC
PYC Therapeutics Seeks ASX Quotation for 354.8 Million New Shares
PremiumCompany Announcements
PYC Therapeutics Seeks ASX Quotation for 354.8 Million New Shares
3M ago
PYC
PYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline
PremiumCompany Announcements
PYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline
3M ago
PYC
PYC Therapeutics launches major entitlement offer and placement to fund RNA therapy programs
PremiumCompany Announcements
PYC Therapeutics launches major entitlement offer and placement to fund RNA therapy programs
3M ago
PYC
PYC Therapeutics Opens Retail Component of Entitlement Offer to Fund RNA Therapy Pipeline
PremiumCompany AnnouncementsPYC Therapeutics Opens Retail Component of Entitlement Offer to Fund RNA Therapy Pipeline
3M ago
PYC
PYC Therapeutics Sets Investor Webinar to Detail Capital Raise and Pipeline Progress
Premium
Company Announcements
PYC Therapeutics Sets Investor Webinar to Detail Capital Raise and Pipeline Progress
3M ago
PYC
PYC Therapeutics Secures A$537m in Institutional Raising, Extends Cash Runway to 2030
Premium
Company Announcements
PYC Therapeutics Secures A$537m in Institutional Raising, Extends Cash Runway to 2030
3M ago
PYC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >